These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19553800)

  • 21. Neovascular age-related macular degeneration: too many theories, too little knowledge?
    Kvanta A
    Acta Ophthalmol; 2008 Aug; 86(5):468-9. PubMed ID: 18752524
    [No Abstract]   [Full Text] [Related]  

  • 22. Subfoveal exudative age-related macular degeneration: evidence for preoccult disease.
    Shah AR; Del Priore LV
    Curr Opin Ophthalmol; 2009 May; 20(3):182-7. PubMed ID: 19367162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 2].
    Zueva MV; Tsapenko IV; Riabina MV; Grinchenko MI; Neroeva NV
    Vestn Oftalmol; 2009; 125(4):55-9. PubMed ID: 19824452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of radiation trials for age-related macular degeneration.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S34-5. PubMed ID: 19553797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
    Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rapidly evolving diagnosis and treatment of age-related macular degeneration.
    Optometry; 2009 Feb; 80(2):101-6. PubMed ID: 19195112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Para-inflammation in the aging retina.
    Xu H; Chen M; Forrester JV
    Prog Retin Eye Res; 2009 Sep; 28(5):348-68. PubMed ID: 19560552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular degeneration: types, causes, and possible interventions.
    Feret A; Steinweg S; Griffin HC; Glover S
    Geriatr Nurs; 2007; 28(6):387-92. PubMed ID: 18068822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery strategies for combination ophthalmic treatments.
    Kuppermann BD
    Retina; 2009 Jun; 29(6 Suppl):S24-6. PubMed ID: 19553793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination angiostatic therapies: current status.
    Peyman GA; Fiscella R; Conway M
    Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 1].
    Zueva MV; Tsapenko IV; Riabina MV; Grinchenko MI; Neroeva NV
    Vestn Oftalmol; 2009; 125(4):51-4. PubMed ID: 19824451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration.
    Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S
    Retina; 2009; 29(10):1450-6. PubMed ID: 19816240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple modality treatment of patients with senile central chorioretinal dystrophy with use of electromagnetic field].
    Markov GS; Iuzhakov AM; Evsegneeva IV; Ktsnel'son LA; Burgova NS; Nosova VP; Kozlov LV; Mishin AA; Markarova IS; Komarova ET; Zaslavskiĭ AIu
    Vestn Oftalmol; 2000; 116(3):41-3. PubMed ID: 10918853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy using the small interfering RNA bevasiranib.
    Singerman L
    Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of hypoxia-regulated, RPE-targeted gene therapy for choroidal neovascularization.
    Smith GW; Dorey CK; Prentice H; Blanks J
    Adv Exp Med Biol; 2012; 723():269-77. PubMed ID: 22183342
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathogenesis of age-related macular degeneration].
    Kaarniranta K; Seitsonen S; Paimela T; Meri S; Immonen I
    Duodecim; 2009; 125(2):145-53. PubMed ID: 19341030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection in the peripheral nervous system: rationale for more effective therapies.
    Höke A
    Arch Neurol; 2006 Dec; 63(12):1681-5. PubMed ID: 17172606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.